These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38390768)

  • 1. Impact of Drug Recalls on Patients in The Netherlands: A 5-Year Retrospective Data Analysis.
    Annema PA; Derijks HJ; Bouvy ML; van Marum RJ
    Clin Pharmacol Ther; 2024 Jun; 115(6):1365-1371. PubMed ID: 38390768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug switching in the Netherlands: a cohort study of 20 active substances.
    Glerum PJ; Maliepaard M; de Valk V; Burger DM; Neef K
    BMC Health Serv Res; 2020 Jul; 20(1):650. PubMed ID: 32660480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of FDA drug recalls: A 30-month analysis.
    Hall K; Stewart T; Chang J; Freeman MK
    Am J Health Syst Pharm; 2016 Feb; 73(4):235-40. PubMed ID: 26843501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A four-year assessment of the characteristics of Rwandan FDA drug recalls.
    Bahizi M; Nyirimigabo E; Ntirenganya L; Umuhoza MI; Habyalimana V; Bikorimana G; Ukwishaka J
    BMC Public Health; 2024 Jul; 24(1):1784. PubMed ID: 38965502
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Categorization and comparisons of drug recalls for manufacturers and compounders.
    Mattingly AN; Mattingly TJ; Nguyen Phan AL; Negash K
    J Am Pharm Assoc (2003); 2022; 62(4):1344-1350. PubMed ID: 35422393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Trends in Non-prescription Drug Recalls in Japan].
    Yamamoto C; Ishida T; Osawa T; Naito T; Kawakami J
    Yakugaku Zasshi; 2016; 136(9):1307-12. PubMed ID: 27592833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of generic switching on concerns about medicine and non-persistence among Danish adults in a general practice setting.
    Rathe JØ
    Dan Med J; 2015 Oct; 62(10):B5148. PubMed ID: 26441397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of Medicines in Portugal: A Retrospective Review of Medicine Recalls (2000-2015).
    Machado Reis AT; Berardo BFR; Loureiro R
    PDA J Pharm Sci Technol; 2018; 72(1):44-49. PubMed ID: 29030530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brand and generic use of inhalation medication and frequency of switching in children and adults: A population-based cohort study.
    Engelkes M; van Blijderveen JC; Overbeek JA; Kuiper J; Herings RCM; Sturkenboom MCJM; de Jongste JC; Verhamme KMC; Janssens HM
    J Asthma; 2018 Oct; 55(10):1086-1094. PubMed ID: 29185812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview of high-risk medical device recalls in obstetrics and gynecology from 2002 through 2016: implications for device safety.
    Janetos TM; Ghobadi CW; Xu S; Walter JR
    Am J Obstet Gynecol; 2017 Jul; 217(1):42-46.e1. PubMed ID: 28500861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reflections of the Angiotensin Receptor Blocker Recall by the FDA and Repercussions on Healthcare.
    Gillette M; Taylor A; Butulija D; Kadiyala H; Jneid H
    Cardiovasc Drugs Ther; 2020 Aug; 34(4):579-584. PubMed ID: 32318933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Analytic Investigation of the Drug Formulation-Based Recalls in the USA: See More Beyond the Literal.
    Yang M; Byrn SR; Clase KL
    AAPS PharmSciTech; 2020 Jul; 21(5):198. PubMed ID: 32676955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of national valsartan recalls on Veterans' outcomes.
    Morizio PL; Britnell SR; Ottman AA
    Ther Adv Drug Saf; 2021; 12():20420986211016173. PubMed ID: 34249328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The continuing challenge of drug recalls: Insights from a ten-year FDA data analysis.
    Ghijs S; Wynendaele E; De Spiegeleer B
    J Pharm Biomed Anal; 2024 Jul; 249():116349. PubMed ID: 39029352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy discontinuation or substitution in patients with cardiovascular disease, switching among different products of the same off-patent active substance: a 'real-world' retrospective cohort study.
    Degli Esposti L; Sangiorgi D; Buda S; Degli Esposti E; Scaglione F
    BMJ Open; 2016 Nov; 6(11):e012003. PubMed ID: 27807083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between prescription change frequency, chronic disease score and hospital admissions: a case control study.
    Sino CG; Stuffken R; Heerdink ER; Schuurmans MJ; Souverein PC; Egberts TA
    BMC Pharmacol Toxicol; 2013 Aug; 14():39. PubMed ID: 23915423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Product recall: a Croatian experience (2000-2010).
    Vuk T; Barišić M; Ljubičić J; Hećimović A; Juraković-Lončar N; Šarlija D; Jukić I
    Blood Transfus; 2013 Jul; 11(3):433-40. PubMed ID: 23114522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major FDA medical device recalls in ophthalmology from 2003 to 2015.
    Talati RK; Gupta AS; Xu S; Ghobadi CW
    Can J Ophthalmol; 2018 Apr; 53(2):98-103. PubMed ID: 29631834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a Forced Dose-Equivalent Levothyroxine Brand Switch on Plasma Thyrotropin: A Cohort Study.
    Flinterman LE; Kuiper JG; Korevaar JC; van Dijk L; Hek K; Houben E; Herings R; Franken AAM; de Graaf JP; Horikx A; Janssens M; Meijer R; Wijbenga A; van Puijenbroek E; Wolffenbuttel BHR; Links TP; Bisschop PH; Fliers E
    Thyroid; 2020 Jun; 30(6):821-828. PubMed ID: 32188356
    [No Abstract]   [Full Text] [Related]  

  • 20. Analyzing generic and branded substitution patterns in the Netherlands using prescription data.
    Pechlivanoglou P; van der Veen WJ; Bos JH; Postma MJ
    BMC Health Serv Res; 2011 Apr; 11():89. PubMed ID: 21524312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.